<DOC>
	<DOC>NCT02879877</DOC>
	<brief_summary>This study is designed to evaluate the safety and tolerability of UCB7858 when given as single ascending doses administered by intravenous or subcutaneous infusion in healthy subjects.</brief_summary>
	<brief_title>A First-In-Human Study With a Single Ascending Dose of UCB7858 in Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Healthy male and female volunteers who gave their written consent by signing the Informed Consent Form Subjects in the age between 18 and 55 years old with normal weight as determined by a body mass index (BMI) between 18 and 30 kg/m^2, with a body weight of at least 50 kg for male subjects or 45 kg for female subjects Subject has clinical laboratory test results within the reference ranges of the testing laboratory (including normal renal and liver function) or test results that are outside the specified ranges and that are deemed as clinically nonsignificant Subjects has blood pressure (BP) and pulse within normal range in a supine position after 5 minutes rest Subject's electrocardiogram (ECG) is considered 'normal' or 'abnormal' but clinically nonsignificant Subject has any medical or psychiatric condition that, in the opinion of the Investigator, could jeopardize or would compromise the subject's ability to participate in this study: Subject has any acute or chronic illness which, in the opinion of the Investigator, may place the subject at risk because of participation in the study. Subject has any clinically relevant abnormal findings in physical examination, laboratory tests, vital signs, or ECG, which, in the opinion of the Investigator, may place the subject at risk because of participation in the study. Tests positive for Human Immunodeficiency Virus (HIV)1 or2 antibodies, Hepatitis B Virus (HBV) surface antigen, or Hepatitis C Virus (HCV) antibody Hepatic impairment Renal impairment Any of the following hematological function tests at the Screening Visit: Hemoglobin &lt;111g/L (for women) or &lt;113g/L (for men); Absolute neutrophil count &lt;1.5x10^9/L (&lt;1000/mm^3); Platelets &lt;150x10^9/L</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>First in human</keyword>
	<keyword>subjects</keyword>
</DOC>